berzosertib able target tumor cells affecting healthy cells prof lord said new clinical trial test safety brand new family targeted cancer drugs people encouraging clinical responses early stage said professor johann de bono head drug development icr royal marsden future drugs boost effect treatments like chemotherapy tackle resistance develop targeted treatments added traditional approach cancer treatment categorize tumor site breast cancer lung cancer precision medicine approach targets genetic abnormality tumor regardless precision approaches example prostate cancers block effect testosterone hormone involved tumor growth provide aggressive option chemotherapy attacks cells indiscriminately phase trialing berzosertib way official report says saudi crown prince